Stocks are plunging with the Dow tumbling over 1,000 points amid renewed concerns over a second coroanvirus wave. Charles Schwab Chief Investment Strategist Liz Ann Sonders joins Heidi Chung to discuss....
ERoad’s new Smart Short Haul feature assists fleets by automatically switching rulesets when drivers breach either the on-duty or air-mile limits of the short haul exemption. ...
Ohio Attorney General Dave Yost joins Yahoo Finance’s Kristin Myers and Zack Guzman to discuss the push from some advocates to defund the police, in the wake of the death of George Floyd....
Payden & Rygel Chief Economist Jeffrey Cleveland joins Yahoo Finance's Zack Guzman to discuss his outlook on the economy after 1.54 million Americans file for unemployment benefits....
Shares of Gilead Sciences, Inc. (NASDAQ: GILD) traded lower by 4% on Thursday amid broad market weakness following a spike in U.S. coronavirus cases.Gilead's remdesivir is one of the most advanced potential treatments for COVID-19, but several options traders made large bets on Thursday that the stock is headed lower.The Gilead TradesOn Thursday, Benzinga Pro subscribers received nine alerts related to unusually large Gilead option trades. Here are the largest: * At 9:33 a.m. ET, a trader sold 1,000 Gilead call options with a $75 strike price expiring on June 19. The contracts were sold near the bid price at $2.11 and represented a $211,000 bearish bet. * At 9:34 a.m. ET, a trader sold another 1,309 of the same Gilead call options with a $75 strike price expiring on June 19. The contracts were sold near the bid price at $1.87 and represented a $244,783 bearish bet. * At 10:19...
